- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Wall Street Savant, LLC ( http://www.wallstreetsavant.com ) today announced initiation of Profile Coverage on Eugene Science, Inc. on its website.
Eugene Science, Inc. is a global Biotechnology company tackling ailments such as heart disease, obesity and diabetes through innovation in the Nutraceutical field. Its first commercial heart disease product, CZ™ is a patented, Nanoscience-based, water-soluble functional food ingredient containing natural plant sterols that help maintain healthy cholesterol levels by inhibiting its absorption.
Eugene Science is advancing the era of Pharmacogenomics, a pioneering field of Biotechnology, which is the predictive and personalized treatment of adult disease through individualized manipulation of foods, medicines, food and genes. These advances are made possible by the combination of Eugene Science's database on adult diseases combined with the Company's applied Bioinformatics technology.
To view Eugene Science's Profile please visit http://www.wallstreetsavant.com .
WallStreetSavant.com is a leading online financial portal where investors can discover an array of financial tools to help build their investment IQ. WallStreetSavant.com also provides comprehensive profiles on undiscovered and under-followed micro and small-cap companies as well as well researched opinions on stocks for active traders. The comprehensive profiles are featured on WallStreetSavant.com and members are kept abreast on all new developments through regular email updates.
To join their free email list please click here:
To feature your publicly traded company on WallStreetSavant.com, please contact them at 1-800-281-6469 or via email at
Forward-Looking Statements: With the exception of historical information, this news release and accompanying information may include forward-looking statements that involve a number of risks and uncertainties. Actual results could differ materially from those anticipated as a result of various risks. There are numerous factors that could contribute to such differences; therefore, such projected events and anticipated results are not warranties or guarantees that such events will occur or that the Company will achieve such results. For more information about this corporation and risks involved in the investment of their publicly traded shares, please see the Company's web site, and/or documents filed with the SEC. Disclosure: Wall Street Savant LLC expects to be compensated fifty thousand shares of EUSI by a non-controlling third party for profile coverage. Wall Street Savant LLC is not a registered investment advisers or broker/dealer. Wall Street Savant LLC makes no recommendation that the purchase of securities of companies profiled in its web site is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
For more information, please click here
Wall Street Savant, LLC
Copyright © WallStreetSavant.comIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Industrial Nanotech, Inc. Provides Shareholder Update August 22nd, 2016
Leading Advanced Materials Manufacturer Pixelligent Closes $10.4 Million in Funding: Capital Will Boost Capacity for North American Manufacturing, Drive Asian Expansion, and Continue Innovation in Solid State Lighting and OLED Display Applications August 16th, 2016
Harris & Harris Group to Host a Shareholder Update Call, Including a Presentation by One of Its Precision Health and Medicine Portfolio Companies, Muses Labs, Inc., on August 23, 2016 August 16th, 2016
50 years after the release of the film 'Fantastic Voyage,' science upstages fiction: Science upstages fiction with nanorobotic agents designed to travel in the human body to treat cancer August 25th, 2016
Nanoparticles that speed blood clotting may someday save lives August 23rd, 2016
Semblant to Present at China Mobile Manufacturing Forum 2016 August 25th, 2016